Timasheva, Y,
Badykov, M,
Akhmadishina, L,
Nasibullin, T,
Badykova, E,
Pushkareva, A,
Plechev, V,
Sagitov, I,
Zagidullin, N (2021) of SSS in a prospective cohort of patients admitted to the clinic for pacemaker implantation using
singleZhang, G.,
Zhu, Y.,
Ling, Y.,
Chen, P.,
Dai, J.,
Wang, Ch.,
Xu, Sh.,
Shumadalova, A.,
Shi, H. (2022) strategy for patients with AIS caused by PPCA remains unclear. We discuss our
single-center experience
Motloch, LJ;,
Jirak, P;,
Gareeva, D;,
Davtyan, P;,
Gumerov, R;,
Lakman, I;,
Tataurov, A;,
Zulkarneev, R;,
Kabirov, I;,
Cai, BZ;,
Valeev, B;,
Pavlov, V;,
Kopp, K;,
Hoppe, UC;,
Lichtenauer, M;,
Fiedler, L;,
Pistulli, R;,
Zagidullin, N (2022) single, tertiary care center. Patient clinical and laboratory characteristics and the concentration
,05). It is established that under the influence of ore the structure of
cells of rats' marrow was changed
RNAs that function as regulatory factors have been identified for several complex cellular processes, such as
cellTAMs (tumor-associated macrophages) are innate immune
cells, which are present in prostate cancer
Zhang, Lu,
Wang, Yi-ning,
Ju, Jia-ming,
Shabanova, Azaliia,
Li, Yue,
Fang, Ruo-nan,
Sun, Jia-bin,
Guo, Ying-ying,
Jin, Tong-zhu,
Liu, Yan-yan,
Li, Tian-yu,
Shan, Hong-li,
Liang, Hai-hai,
Yang, Bao-feng (2020) dysfunction, eventually developing into heart failure. Mzb1 (Marginal zone B and B1
cell specific protein 1
Bogliolo, M.,
Catucci, I.,
Caleca, L.,
Lasheras, S.V.,
Pujol, R.,
Kiiski, J.I.,
Muranen, T.A.,
Barnes, D.R.,
Dennis, J.,
Michailidou, K.,
Bolla, M.K.,
Leslie, G.,
Figlioli, G. (2019) deleterious affecting
cell survival and chromosome stability with FANCM:p.Arg658* causing more severe
Ivanenkov, Y.A.,
Yu. Filyaeva, K.,
Matniyazov, , R.T.,
Baymiev, A.K.,
Baymiev, A.K.,
Vladimirova, A.A.,
Yamidanov, R.S.,
Mavzyutov, A.R.,
Zileeva, Z.R.,
Zainullina, L.F.,
Vakhitova, J.V.,
Marina, V.I.,
Terentiev, V.A.,
Osterman, I.A.,
Kartsev, V.G.,
Bezrukov, D.S.,
Dontsova, O.A. (2021) compound exhibited an MIC of 13.5 µM (6.25 µg/ml) and a relatively low cytotoxicity against HEK293
cells